Quantitative analysis of epidermal innervation in Fabry disease

Neurology

Volumn 52, Issue 6, 1999, Pages 1249-1254

  Scott, L J C ^a   Griffin, J W ^b   Luciano, C ^c   Barton, N W ^c   Banerjee, T ^c   Crawford, T ^b   McArthur, J C ^b   Tournay, A ^c   Schiffmann, R ^c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FABRY DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KIDNEY FUNCTION; NERVE CONDUCTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SKIN BIOPSY; SKIN NERVE; SURAL NERVE;

EID: 0032944086     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.6.1249     Document Type: Article

References (27)

1. Brady RO, Gal EA, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry's disease: ceramide trihexosidase deficiency. N Engl J Med 1967;246:1163-1167.
2. Sweeley CC, Klionsky B. Fabry's disease: classificationas a sphingolipidosis and partial characterization of a novel glycolipid. J Biol Chem 1963;238:3148-3150.
3. Grunnert ML, Spilsbury PR. The central nervous system in Fabry's disease: an ultrastructural study. Arch Neurol 1973; 28:231-234.
4. Kaye EM, Kolodny EH, Logigian EL, Ullman MD. Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation. Ann Neurol 1988;23:505-509.
5. Hozumi I, Nishizawa M, Ariga T, et al. Accumulation of glycosphingolipids in spinal and sympathetic ganglia of a symptomatic heterozygote of Fabry's disease. J Neurol Sci 1989;90: 273-280.
6. Tabira T, Goto I, Kuriowa Y. Neuropathological and biochemical studies in Fabry's disease. Acta Neuropathol (Berl) 1974; 30:345-354.
7. Tagliavani F, Pietrini V, Gemignani F, et al. Anderson-Fabry's disease: neuropathological and neurochemical investigation. Acta Neuropathol (Berl) 1982;56:93-98.
8. Rahman AN, Lindenberg R. The neuropathology of hereditary dystrophic lipidosis. Arch Neurol 1963;9:373-385.
9. Sung JH. Autonomic neurons affected by lipid storage in the spinal cord in Fabry's disease: distribution of autonomic neurons in the sacral cord. J Neuropathol Exp Neurol 1979;38:87-98.
10. Steward VW, Hitchcock C. Fabry's disease (angiokeratoma corporis diffusum): a report of 5 cases with pain in the extremities as the chief symptom. Pathol Eur 1968;3:377-388.
11. deVeber GA, Schwarting GA, Kolodny EH, Kowall NW. Fabry disease: immunocytochemical characterization of neuronal involvement. Ann Neurol 1992;31:409-415.
12. Kahn P. Anderson-Fabry disease: a histopathological study of three cases with observations on the mechanism of production of pain. J Neurol Neurosurg Psychiatry 1973;36:1053-1062.
13. Russell JW, Luciano CA, Banerjee TK, et al. Clinical and electrophysiological studies of myelinated and unmyelinated fiber functions in Fabry disease. Neurology 1995;45(suppl 4): A227. Abstract.
14. Ohnishi A, Dyck PJ. Loss of small peripheral sensory neurons in Fabry disease. Arch Neurol 1974;31:120-127.
15. Kocen RS, Thomas PK. Peripheral nerve involvement in Fabry's disease. Arch Neurol 1970;22:81-88.
16. Dalsgaard CJ, Rydh M, Haegerstrand A. Cutaneous innervation in man with protein gene product 9.5 (PGP 9.5) antibodies. Histochemistry 1989;92:385-390.
17. McCarthy BG, Hsieh S-T, Stocks A, et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995;45:1848-1855.
18. Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 1996;47:1042-1048.
19. Holland NR, Stocks A, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology 1997;48:708-711.
20. Kusiak JW, Quirk JM, Brady RO. Purification and properties of the two major isozymes of a-galactosidase from human placenta. J Biol Chem 1978;253:184-190.
21. Nielson VK. The peripheral nerve function in chronic renal failure: VI. The relationship between sensory and motor nerve conduction and kidney function, azotemia, age, sex, and clinical neuropathy. Acta Med Scand 1973;194:455-462.
22. Buchthal F, Rosenfalck A. Evoked action potentials and conduction velocity in human sensory nerves. Brain Res 1966;3: 1-122.
23. Kimura J. Electrodiagnosis in diseases of nerve and muscle. Philadelphia: F.A. Davis Co., 1989.
24. Shefner J, Buchthal F, Krarup C. Slowly conducting myelinated fibers in peripheral neuropathy. Muscle Nerve 1991;14: 534-542.
25. Li Y, Hsieh ST, Chien HF, Zhang X, McArthur JC, Griffin JW. Sensory and motor denervation influence epidermal thickness in rat foot glabrous skin. Exp Neurol 1997;147:452-462.
26. Devor M, Schonfeld D, Seltzer Z, Wall PD. Two modes of cutaneous reinnervation following peripheral nerve injury. J Comp Neurol 1979;185:211-220.
27. Doucette R, Diamond J. Normal and precocious sprouting of nociceptors in the skin of adult rats. J Comp Neurol 1987;261: 592-603.